The proposal would update 42 CFR Part 2, which outlines privacy standards for medical records detailing addiction treatment.
The changes would permit physicians to input substance use disorder treatment into a patient’s medical history with his or her consent.
“The lack of critical substance use history in a patient’s medical record can lead to potentially damaging consequences for a person with a substance use disorder,” Elinore McCance-Katz, MD, PhD, HHS assistant secretary for mental health and substance use, said in a statement. “This rule aims to ease the sharing of information, reduce burden for providers and increase access to care for individuals while at the same time maintaining important privacy controls.”
The proposal comes about three weeks after the National Association of Attorneys General sent a letter to members of Congress, urging them to remove federal treatment barriers for opioid use disorder, including the “out-of-date” privacy rules.
More articles on opioids:
Florida, Military Health System to share PDMP data
The challenges of lowering opioid prescriptions
More than half of privately insured kids getting tonsils removed receive opioids
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
